# EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL.

> **NCT07543640** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Eman Raafat Said** · enrollment: 56 (estimated)

## Conditions studied

- Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital Psoriasis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Roflumilast 500 Mcg Oral Tablet

## Key facts

- **NCT ID:** NCT07543640
- **Lead sponsor:** Eman Raafat Said
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07543640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07543640, "EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07543640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*